Durvalumab and Tremelimumab for Unresectable Hepatocellular Cancer
Kathryn Green, MSN, ACNP-BC Hepatocellular cancer (HCC) is a common cancer globally, and there are more than 40,000 new cases yearly with an estimated 29,380 deaths per year in the…
Kathryn Green, MSN, ACNP-BC Hepatocellular cancer (HCC) is a common cancer globally, and there are more than 40,000 new cases yearly with an estimated 29,380 deaths per year in the…
Beth Sandy, MSN, CRNP As oncology continues to gravitate towards precision medicine and a personalized approach to treatment, we are seeing increased numbers of oral targeted therapies being approved and…
Kim Navarrete, MSN, APRN, FNP-C, OCN, and Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP Multiple myeloma (MM) is a hematologic malignancy associated with the clonal proliferation of plasma cells. Despite decades of…
Alana Rothman, FNP My dad was 64 years old—active, social and otherwise healthy—when he was diagnosed with glioblastoma multiforme. We didn’t appreciate what the diagnosis meant when it was given,…
Karla V. Ow, MSN, FNP, AOCNP Chimeric antigen receptor (CAR) T cells are lymphocytes that have been genetically modified to produce a CAR that specifically targets tumor cell antigens.1 CAR…
An interest in cancer survivorship gave advanced practice providers (APPs) an opportunity to contribute to patient care and the growth of the Oklahoma Cancer Specialists and Research Institute (OCSRI), a…
Part 2 of a two-part series Click here to read Part 1: Fertility Preservation Provides Options for Patients With Cancer How to Talk About Fertility Preservation Options With Young Patients…
Patients with cancer may struggle to understand medical terminology healthcare professionals use, leading to missed opportunities for early detection or effective treatment. Advanced practice providers are frequently at the forefront…
Anna Poullard, DNP, ACNP-BC Clinical trials play an important role in enhancing outcomes in the treatment of patients with cancer. Oncology clinical trials provide the necessary data about the safety…